Not available
Quote | Sarepta Therapeutics Inc. (NASDAQ:SRPT)
Last: | $122.84 |
---|---|
Change Percent: | 0.73% |
Open: | $124.09 |
Close: | $122.84 |
High: | $125.89 |
Low: | $120.34 |
Volume: | 998,607 |
Last Trade Date Time: | 06/14/2024 03:00:00 am |
News | Sarepta Therapeutics Inc. (NASDAQ:SRPT)
2024-06-14 15:00:00 ET More on the markets SPY Is Sub-Optimal For Long-Term Diversified Investors S&P 500 Peaks And VIX Valleys As Market Signals Going Into June, SPY Or VXF, Which Is The Better Buy? (Technical Analysis) Citi says ETFs will engulf U.S. as...
2024-06-13 15:15:01 ET Citigroup analyst issues BUY recommendation for SRPT on June 13, 2024 01:18PM ET. The previous analyst recommendation was Buy. SRPT was trading at $123.865 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ana...
Message Board Posts | Sarepta Therapeutics Inc. (NASDAQ:SRPT)
Subject | By | Source | When |
---|---|---|---|
Congrats to longs. Monday should be a good | XWAVXALMIMAN | investorshub | 05/14/2023 7:17:11 AM |
$SRPT Price gaining up | girlfriend | investorshub | 05/14/2023 7:07:27 AM |
got some short data | Atown62 | investorshub | 05/13/2023 2:41:06 AM |
$SRPT Time for this to show some returns | Atown62 | investorshub | 05/11/2023 2:47:00 PM |
MomentumIts now last up | Atown62 | investorshub | 05/11/2023 8:57:44 AM |
News, Short Squeeze, Breakout and More Instantly...
Sarepta Therapeutics Inc. Company Name:
SRPT Stock Symbol:
NASDAQ Market:
Sarepta Therapeutics Inc. Website:
Pfizer (NYSE: PFE) announced that a phase III study on its mini-dystrophin gene therapy fordadistrogene movaparvovec for treating Duchenne muscular...
2024-06-13 15:15:01 ET Citigroup analyst issues BUY recommendation for SRPT on June 13, 2024 01:18PM ET. The previous analyst recommendation was Buy. SRPT was trading at $123.865 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ana...
2024-06-13 11:00:06 ET Brian Skorney from Robert W. Baird issued a price target of $170.00 for SRPT on 2024-06-13 10:14:00. The adjusted price target was set to $170.00. At the time of the announcement, SRPT was trading at $124. The overall price target consensus is at $...